Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Powder inhalation systems].

M Kohlhäufl1, P Haidl, Th Voshaar

  • 1Asklepios Fachklinik München-Gauting, Zentrum für Pneumologie und Thoraxchirurgie, Gauting. m.kohlhaeufl@asklepios.com

Deutsche Medizinische Wochenschrift (1946)
|September 24, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prediction of abdominal CT body composition parameters by thoracic measurements as a new approach to detect sarcopenia in a COVID-19 cohort.

Scientific reports·2022
Same author

[Early Pulmonary Rehabilitation after Long Term Mechanical Ventilation].

Pneumologie (Stuttgart, Germany)·2021
Same author

Pneumologie (Stuttgart, Germany)·2021
Same author

Pneumologie (Stuttgart, Germany)·2020
Same author

[The Role of Air Pollutants for Health - A Reply to the Expert Opinion of the International Society for Environmental Epidemiology (ISEE) and the European Respiratory Society (ERS)].

Pneumologie (Stuttgart, Germany)·2019
Same author

[Tremendous Increase of Home Care in Ventilated and Tracheostomized Patients - Reasons, Consequences, Solutions].

Pneumologie (Stuttgart, Germany)·2019
Same journal

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

["Not everything that looks like a tumor..." - Pulmonary tularemia with hilar lymphadenopathy].

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[Emergency management of sickle cell disease].

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[Hereditary dehydrated stomatocytosis (= hereditary xerocytosis) - Interesting hummingbird or clinically relevant diagnosis?]

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[Diagnosis of Congenital Hemolytic Anemias in Adults].

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[46-year-old female patient with right upper abdominal pain].

Deutsche medizinische Wochenschrift (1946)·2026
See all related articles

Dry powder inhalers (DPIs) deliver bronchodilators and corticosteroids for obstructive lung diseases. Proper patient technique and device selection are crucial for effective aerosol delivery and lung deposition.

Area of Science:

  • Pulmonary Medicine
  • Pharmacology
  • Biomedical Engineering

Context:

  • Obstructive lung diseases like asthma and COPD are commonly treated with inhaled bronchodilators and corticosteroids.
  • A wide variety of dry powder inhaler (DPI) devices and drug formulations are available, leading to potential confusion for healthcare providers and patients.
  • Different inhaler types, such as pressurized metered-dose inhalers (pMDIs) and DPIs, may require different dosing strategies.

Purpose:

  • To elucidate the mechanisms of aerosol generation and lung deposition for DPIs.
  • To highlight the critical factors influencing the efficacy of DPIs, including patient inhalation technique, device design, and environmental conditions.
  • To provide guidance on the appropriate use of DPIs in managing obstructive lung diseases.

Summary:

Related Experiment Videos

  • DPIs function by generating aerosols from dry powder formulations, where drug particles are either micronized or attached to larger carrier particles.
  • Effective drug release and lung deposition from DPIs depend on patient inhalation flow rates (30-120 L/min), device-specific resistance, and environmental factors like humidity and temperature.
  • Optimal patient outcomes necessitate consistent use of a single device type and regular instruction on correct inhalation technique.

Impact:

  • DPIs are recommended for the prophylactic and maintenance treatment of asthma and COPD.
  • DPIs are not suitable for patients experiencing acute severe bronchoconstriction or for children under 5 years of age.
  • Standardizing device use and patient education can improve therapeutic adherence and treatment effectiveness for inhaled therapies.